SCIENTIFIC PROGRAMME
The meeting will consist of early morning plenary sessions, symposia and lunchtime workshops - together with oral and poster presentations from abstracts submitted.

PLENARY SESSIONS
P. PooleWilson, London (UK). President, World Heart Federation
Prevention of cardiovascular disease: who are the victims and who are the health providers?

S. Mendis, Geneva (CH). Coordinator, Cardiovascular Disease programme, World Health Organisation
Overcoming the challenges of secondary prevention of cardiovascular disease

K. Srinath Reddy, New Dehli (IN). Coordinator, Initiative for Cardiovascular Health Research in Developing Countries
Overcoming the challenges of secondary prevention of cardiovascular disease in developing countries

SATELLITE SYMPOSIA
Sponsored by Boehringer Ingleheim:
K.K. Teo, Ontario (CA). Professor of Medicine and Chief of Cardiology, McMaster University Medical Centre.
Modulation of the RAS in secondary prevention

Sponsored by Solvay Healthcare
J. Halcox, London (UK). Al Maktoum Senior Lecturer in Cardiology, British Heart Foundation.
Secondary prevention post MI: Role of highly purified Omega-3-PUFAS to reduce mortality

SYMPOSIA
The five sessions will run concurrently for the three days of the congress.
Sessions A, B & C are Invited Symposia, with the exception on C4 which is an Oral Presentation Session
Sessions D & E are Oral Presentation sessions, with the exception of D2, D3 and D4 which are Invited Symposia

Symposium A1: The evidence base for cardiac rehabilitation
Chairs: W. Fennell, (IE) and N. Wenger, (US)
Cardiac rehabilitation: the science behind the practice
H. Saner, Bern (CH)
Cardiac rehabilitation: findings from Cochrane reviews
R. Taylor, Birmingham (UK)
The economic profile of cardiac rehabilitation services
N. Oldridge, Indianapolis (US)

Symposium A2: Models of delivery of cardiac rehabilitation: what will services look like in the future?
Chairs: P. Mathes, (DE) and M. Varma, (IE)
The COACH Programme
M. Jelinek, Melbourne (AU)
After the Heart Manual:new challenges to cardiac rehabilitation
R. Lewin, York (UK)
Brief interventions: the Beaumont 4 vs 10-week programme
A. Cahill, Dublin (IE)
Computerised management of cardiovascular risk: ADAPT and RHASP
E. O’Brien, Dublin (IE)
Risk reduction via the internet: an intervention case management model
K.Berra, Stanford (US)

Symposium A3: Does exercise training have a role in contemporary cardiology?
[Symposium sponsored by the ESC Working Group on Cardiac Rehabilitation and Exercise Physiology]
Chairs: H. Bjornstad (NO) and T. Kavanagh, (CA)
Promises and problems of epidemiological studies of exercise for primary prevention
H. Saner, Bern (CH)
Exercise training to treat stable angina and heart failure
R. Hambrecht, Leipzig (DE)
Physical fitness and physical activity: separate heart disease risk factors?
J. Myers, Palo Alto (US)

Symposium A4: Exercise testing: special needs for special groups
[Symposium sponsored by the ESC Working Group on Cardiac Rehabilitation and Exercise Physiology]
Chairs: G. Fletcher, (US) and B. Bjsrnasan, (DE)
Exercise testing in persons with disabilities
T. Abel, Cologne (DE)
Exercise testing in children and adolescents with congenital heart diseases
P.M. Fredriksen, Oslo (NO)
Impact of exercise testing in grown-up congenital heart disease (GUCH)
W. Budts, Leuven (BE)

Symposium A5: Exercise: how much is enough?
Chairs: H. Goelke, (DE) and V. Maher, (IE)
The role of exercise in maintaining health
S Blair, Dallas (US)
Targeting the effects of exercise training
P Ades, Vermont (US)
Exercise dosage and optimising health outcomes
R. Humphrey, Pocatello (US)
The impact of exercise on healthcare costs
R. Luepker, Minneapolis (US)

Symposium A6: Exercise: can it be bad for your health?
Chairs: R. Mulcahy, (IE) and M. Jelinek, (AU)
Relative benefits of strenuous vs less strenuous exercise in cardiovascular disease
G. Fletcher, Atlanta (US)
High risk activities: putting the risks of exercise in perspective
B. Franklin, Royal Oak(US)
Sudden death during exercise
P. Thompsen, Philadelphia (US)

Symposium A7: Genetic contributions to maximal exercise capacity and training effects
[Symposium sponsored by the ESC Working Group on Cardiac Rehabilitation and Exercise Physiology]
Chairs: M. Mendes (PT) and A. Cohan Solal, (FR)
Genetics and exercise testing: findings from the Family Heritage study
T. Rankinen, Baton Rouge (US)
Determinants of exercise capacity and training effect: genetic contributions
L. Vanhees, Leuven (BE)
The CAREGENE study: ACE gene I/D polymorphism and trainability of aerobic power in coronary artery disease
J. Defoor, L. Vanhees, K. Martens, G. Matthijs, E. Legius, A. Van Vierken, D. Schepers, R.Fagard, Leuven (BE)
Influence of exercise training onendothelial expression and function of angiotensin II-receptors in patients with coronary artery disease
V. Adams, S.Erbs, Y. Shu, J.F. Gummen, N.Krantel, F.W. Mohr, G. Schuler, R. Hambrecht, Leipzig (DE)
Exercise training and circulating progenitor cells in patients with coronary artery disease and peripheral arterial occlusive disease
M. Sandri, K. Lenk, V. Adams, S. Gielen, D. Scheinert, D. Schmidt, J. Boeger, A.Tarrok, G. Schuler, R.Hambrecht, Leipzig (DE)
Impact of exercise intensity on the expression of antherogenic adhesion molecules in both diabetic and non-diabetic patients with coronary artery disease
T. Peschel, S. Sixt, G. Muth, F. Beitz, A. Tarnok, J. Niebaver, Leipzig (DE)

Symposium A8: New cardiac populations: the cardiac rehabilitation challenges
Chairs: A. McLeod (UK) and R. Hambrecht, (DE)
Implantable defibrillators – exercise challenges
L. Vanhees, Leuven (BE)
Synchronised pacing - exercise challenges
P. Sellier, Paris (FR)
Implantable devices and new cardiac populations – psychological challenges
S. Lewin, York (UK)

Symposium A9: Corporate wellness - from prevention to rehabilitation
[Symposium sponsored by Quinton]
Chairs: R. Humphrey, (US) and D. Dugmore, (UK)
Stress and cardiovascular risk in the English football league managers: a cause for concern?
D. Dugmore, Manchester (UK)
Cardiovascular risk assessment and management in the corporate setting: The Stanford experience
B. Haskell, Palo Alto (US)
The role of the physician in primary prevention: the Lifesigns USA experience
L. Rice, San Diego (US)
"Why wrestle when you can dance?" Behavioural and lifestyle interventions that can be applied to corporate wellness and cardiac rehabilitation
R. Scales, Albuquerque (US)

Symposium A10: Heart failure: the rehabilitation challenge
Chairs: K. McDonald, (IE) and U. Corra (IT)
Heart failure: the current epidemiological and clinical profile
I. Pina, Pittsburgh (US)
Cardiac cachexia: can it be reversed?
P. Dubach, Chur (CH)
The effect of exercise on the remodelling process
P. Giannuzzi, Veruno (IT)
Heart failure patients: rehabilitation issues and strategies
A. Stromberg, Linkoping (SE)

Symposium A11: Challenges in the rehabilitation of congestive heart failure (CHF) patients
[Symposium sponsored by the ESC Working Group on Cardiac Rehabilitation and Exercise Physiology]
Chairs: P. Fioretti, (IT) and I. Pina, (US)
Immunomodulating effects of exercise in CHF
R. Adampoulos, Athens (GR)
The challenge of exercise in the rehabilitation of CHF patients
A. Cohen Solal, Paris (FR)
Beta-blockers and the rehabilitation of CHF patients
H. Goelke, Bad Grozingen (DE)

Symposium A12: Residential vs ambulatory cardiac rehabilitation
Chairs: K. Held, (DE) and K. Berra, (US)
The case for residential rehabilitation
P. Giannuzzi, Veruno (IT)
The case for ambulatory rehabilitation
N. Wenger, Atlanta (US)
Ambulatory rehabilitation in heart failure – a new model
H. Saner, Bern (CH)
Residential and ambulatory rehabilitation – conflicting, competitive, complementary?
D. Karoff, Ennepetal (DE)
Problems in the acceptance of ambulatory programmes
P. Mathes, Munich (DE)

Symposium B1: Creating environments to support heart healthy lifestyles: the role of governmental and other agencies I
Chairs: J. Keily, (IE) and W. Dafoe (CA)
The Irish Cardiovascular Health Strategy: a coordinated national approach by government
M. Kelly, Dublin (IE)
The national service framework for CHD in England
R. Boyle, London (UK)
The national plan for ischemic heart disease management in Spain
J. Velasco, Madrid (ES)
European Union consensus on prevention of cardiovascular disease
E. Shelley, Dublin (IE)

Symposium B2: Creating environments to support heart healthy lifestyles: the role of governmental and other agencies II
Chairs: C. Fitzgerald, (IE) and G. de Backer, (BE)
Strategies to promote physical activity at population level
E. Majestic, Atlanta (US)
Obesity and health-related measures in urban teenagers: the PATH Programme
P. Fardy, New York (US)
Challenges in creating the environment to support heart healthy lifestyles
B. Gaffney, Belfast (UK)
A preventive cardiology educational programme: implementation in a developing country
D. Bellosillo, Manila (PH)

Symposium B3: European prevention guidelines, EuroAspire and EuroAction
Chairs: K. Daly, (IE) and R. Luepker (US)
European guidelines on cardiovascular disease prevention
G de Backer, Ghent (BE)
The EuroAspire Survey: cardiac rehabilitation findings
K. Kotseva, London (UK)
EuroAspire: follow-up of first degree relatives with premature coronary disease
J. de Sutter, Ghent (BE)
EuroAction: a European demonstration project in preventive cardiology
D. Wood, London (UK)
Role of the EuroAction team in managing coronary patients, families and high risk individuals
C. Jennings, London (UK)
SCORECARD and EuroAction: a new tool in cardiovascular disease prevention in primary care
T. Thomsen, Glosterup (DK)

Symposium B4: Guidelines: are they a waste of time?
Chairs: D. Wood, (UK)
European guidelines: the challenge to promote good practice
G. deBacker, Ghent (BE)
American guidelines: benefits and pitfalls
G. Balady, (US)
Medico-legal concerns about guidelines
W. Dafoe, Edminton (CA)
Guidelines in the future: what to expect
I. Graham, Dublin (IE)

Symposium B5: Developments in cardiology: implications for cardiac rehabilitation I
Chairs: A. Dougal, (UK) and W. Dafoe, (CA)
Management of acute myocardial infarction:
N. Campbell, Belfast (UK)
Cardiac devices
N. Mahon, Dublin (IE)
Electrophysiology
D. Keane, Dublin (IE)

Symposium B6: Developments in cardiology: implications for cardiac rehabilitation II
Chairs: P. McKiernan (IE) and P. Sellier, (FR)
Cardiac bypass surgery
J. McCarthy, Dublin (IE)
Valve replacement
A. O'Donnell, Cork (IE)
Paediatric cardiac surgery
M. Redmond, Dublin (IE)

Symposium B7: Lipid disorders and their management
[Symposium supported by an educational grant from AstraZeneca Ireland]
Chairs: J. Feeley, (IE) and K. McDonald, (IE)
Review of the outcomes evidence base of statins
B. Packard, Glasgow (UK)
The pleiotropic effects of statins, their relevance and importance
J. Liao, Cambridge (US)
The future of statin therapy
H. Schuster, Berlin (DE)

Symposium B8: Diabetes: a cardiovascular risk factor?
Chairs: J. Nolan, (IE)
Epidemiology of the metabolic syndrome
B. Balkau, Villejuif (FR)
Glucose and cardiovascular disease in type 2 diabetes
M. Laakso, Oulu (FI)
Coronary artery disease in type 1 diabetes mellitus
H. Colhoun, Dublin (IE)
Early onset type 2 diabetes and its implications for cardiovascular disease
J. Nolan, Dublin (IE)
Diabetes as an atherothromboticsyndrome
P. Grant, Leeds (UK)

Symposium B9: Pharmacological advances and cardiac rehabilitation
[Symposium sponsored by Novartis]
Chairs: C. Davidson, (UK) and W. Weintraub, (US)
Hypertension: recent developments
A. Stanton, Dublin (IE)
Statins: recent developments
M. Murphy, Cork (IE)
Economic implications of pharmacological advances in cardiovascular disease
J. Feeley, Dublin (IE)

Symposium B10: Challenges in delivering secondary prevention
Chairs: G. Balady, (US)
Adherence to secondary prevention therapies
K.K. Teo, Hamilton (CA)
Cost-effectiveness of secondary prevention therapies
W. Weintraub, Atlanta (US)
Secondary prevention – perspectives from Hong Kong
S. Lau, Kowloon (HK)
Secondary prevention – perspectives from Russia
D. Aronov, Moscow (RU)

Symposium B11: The international challenge of obesity
Chairs: E. Froelicher, (US) and P. Fardy, (US)
The current obesity epidemic and its effects in the USA
P. Ades, Vermont (US)
Obesity in Europe
V. Maher, Dublin (IE)
Obesity in Asia
P. Deurenberg, Singapore (SG)
Obesity and the metabolic syndrome in South America
J. Lerman, Buenos Aires (AR)

Symposium B12: Reducing cardiovascular risk through dietary intervention
[Symposium sponsored by Flora]
Chairs:
Plasma homocysteine levels: nutritional and genetic regulations and relationship to disease: the Framingham Study
J. Sehlub, Boston (US)
The role of plant sterols in cholesterol lowering
A. Neil, Oxford (UK)
Omega-3 fatty acids in primary and secondary prevention of coronary disease
E. Schouten, Wageningen (NL)
Current weight loss methods: what works?
M.P. St Onge, New York (US)

Symposium C1: Employment, return to work and cardiovascular disease
Chairs: R. Smyth, (IE) and W. Dafoe, (CA)
Consensus on the duration of sick leave for the cardiac patient? A literature review
J. Perk, Oskarshamm (SE)
Optimising sickness absence: the role of psychological factors
B. Oldenburg, Brisbane (AU)
Optimising sickness absence: the role of cardiovascular factors
J. Niebauer, Leipzig (DE)

Symposium C2: Professional development in cardiac rehabilitation
Chairs: H. Saner, (CH) and J. Horgan, (IE)
Education for cardiac rehabilitation professions in Ireland
H. McGee, Dublin (IE)
Education for cardiac rehabilitation professions in the UK
A. Ross, Glasgow (UK)
Education for cardiac rehabilitation professions in the USA
E. Froelicher, San Francisco (US)
Education for cardiac rehabilitation professions in Australia
P. Davidson, Sydney, (AU)
A cardiac rehabilitation training scheme for cardiologists
H. Saner, Bern (CH)

Symposium C3: Stress and heart disease
Chairs: J. Blumenthal, (US) and L. Earll, (UK)
Overview of stress and cardiovascular disease
S. Bunker, Melbourne (AU)
Psychological stress and its consequences for the cardiovascular system
D. Carroll, Birmingham (UK)
The immune system, inflammatory responses and cardiovascular disease
A. Steptoe, London (UK)

Symposium C4: Stress management
Chairs: A. Steptoe, (UK)
Measuring and managing stress
B. Hughes, Galway (IE)
Relaxation as a technique to enhance outcomes from cardiac rehabilitation
J. van Dixhoorn, Rotterdam (NL)
Hostility: measurement, effects and management
J. Blumenthal, Durham (US)

Symposium C5: Depression and cardiovascular disease
Chairs: H. McGee, (IE) and R. Lewin, (UK)
Depression and recovery from cardiac events
R. Ziegelstein, Baltimore (US)
Identification and psychological management of depression in cardiac patients
P. Bennett, Cardiff (UK)
Physical exercise as a treatment for major depression: evidence and future directions
J. Blumenthal, Durham (US)

C6: Oral Abstract: Employment and cardiac rehabilitation
Chairs: J. Niebauer, (DE)
Return to work after first myocardial infarction in 1991-1996 in Finland
H. Hamalainen, J. Maki, L. Virta, I. Keskimaki, M. Mahonen, V. Moltchanov, V. Salomaa, Helsinki (FI)
A qualitative investigation of return-to-work experiences after a cardiac event
R. Nolan, Dublin (IE)
Assessment of physical capacity, lipid profile and return to work of rehabilitated and non-rehabilitated women with IHD
I. Korzeniowska-Kubacka, K. Mazurek , M. Bilinska, E. Rydzewska, Warsaw (PL)
Cardiovascular risk behaviours in railway workers
D. Zdrenghea, L.I. Poanta, M. Zdrenghea, Cluj-Napoca (RO)
Work readiness and adjustment and self efficacy in cardiac rehabilitation patients
F.T. O’Hagan, S. Thomas, R.L. Franche, Toronto (CA)

Symposium C7: The role of national heart foundations in secondary prevention and cardiac rehabilitation I
[Symposium sponsored by the Irish heart Foundation]
Chairs: W. Fennell, (IE) and B. Hedback (SE)
The approach of the Irish Heart Foundation in cardiac rehabilitation
V. Maher, Dublin (IE)
The approach of the Netherlands Heart Foundation; co-operation and innovation in cardiac rehabilitation
A-M. Strijbis, the Hague (NL)
The approach of the Danish Heart Foundation; influencing the development of cardiac rehabilitation in Denmark
) J. Videbaek, (DK)
The approach of the Singapore Heart Foundation; cardiac rehabilitation in Singapore – past, present and future
A. Asim, Singapore (SG)

Symposium C8: The role of national heart foundations in secondary prevention and cardiac rehabilitation II
[Symposium sponsored by the Irish Heart Foundation]
Chairs: B. Maurer, (IE) and B.M. Lombana, (PA)
The approach of the Heart & Stroke Foundation of Malaysia; cardiac rehabilitation in Malaysia
A.A. Majid, Kuala Lumpur (MY)
The approach of the National Heart Foundation of Australia; cardiac rehabilitation in Australia
S. Bunker, Melbourne (AU)
The approach of the Interamerican Society of Cardiology; cardiac rehabilitation in South and Central America
B.M Lombana, Buenos Aires (AR)
The approach of the Chinese Health Heart Network; cardiac rehabilitation and preventative cardiology in China and East Asia
D. Zhao, Beijing (CN)

Symposium C9:Demographic, social and psychological influences in cardiovascular disease: Implications for cardiac rehabilitation I
Chairs: K.K. Teo, (CA) and K. McGarry (IE)
Socio-economic variations in cardiovascular disease and its management
C. Kelleher, Dublin (IE)
Older populations and cardiac rehabilitation: an overview
H. McGee, Dublin (IE)
Exercise and older cardiac populations
E. Rivas-Estany, Havana (CU)

Symposium C10: Demographic, social and psychological influences in cardiovascular disease: implications for cardiac rehabilitation II
Chairs: I. Hellemans, (NL) and M. Codd (IE)
Women and cardiac rehabilitation: an overview
N. Wenger, Atlanta (US)
Strategies to improve cardiac outcomes for women
K. Berra, Stanford (US)
Illness representations: how patient perceptions influence disease management and outcomes
J. Weinman, London (UK)

Symposium C11: Quality of life outcomes in cardiac rehabilitation
Chairs: R. Taylor, (UK) and S. Charles (IE)
Quality of life: relevance of the concept in the cardiac rehabilitation setting
S. Hoefer, Dublin (IE)
Can available measures of quality of life show changes following cardiac rehabilitation?
D. Hevey, Dublin (IE)
Developing core health-related quality of life instrument across cardiac conditions and interventions
N. Oldridge, Indianapolis (US)

Symposium C12: Smoking: the challenge for cardiac rehabilitation
Chairs: F. Howell (IE) and A. Johan (SG)
Creating a smoke-free environment
L. Clancy, Dublin (IE)
Evidence-based supports for smoking cessation
T. Prins, Amsterdam (NL)
Putting the evidence on smoking cessation into practice
N. Cronin, Dublin (IE)
Building a response to the tobacco epidemic
T. Power, Clane (IE)

Symposium D1: Ageing & cardiac Rehabilitation
Chairs: J. Adgey, (UK) and D. Zhao, (CN)
The implementation of secondary prevention in elderly patients with established coronary artery disease
L. Abboud, J Hir, I Eisen, V Markiewicz, Haifa (IL)
Contrasting mental health and physical functioning quality of life between the old (>75 years) and general phase II cardiac rehabilitation (CR) population
D. Waechter, J Rosneck, J Hughes, R Josephson, Akron (US)
Risk factor assessment and compliance in elderly subjects undergoing cardiac rehabilitation
M. Laher, A Vaughan, T Caren, R Sheils, L Alaexander, G Casimpoy, Dublin (IE)
Cardiac rehabilitation for the elderly
J. Austin, R Williams, L Ross, L Moseley, Abergavenny (US)
Cardiac rehabilitation for the elderly
T. Stenlund, B Lindstrom, M Granlund, G Burell, Umea (SE)
Increasing participation in cardiac rehabilitation in traditionally excluded populations: a qualitative analysis of elderly female and socio-economically deprived patients
A. Clark, W Hearty, HK Whelen, J Dodds, M White, PD MacIntyre, Edmonton (US)

Symposium D2: Adherence to secondary prevention recommendations
Chairs: L. Daly (IE) and M. Johnston (UK)
Types and levels of non-adherence in cardiac rehabilitation
D. Hevey, Dublin (IE)
Behavioural strategies to promote adherence
L. Burke, Pittsburgh (US)
Methods for improving uptake and adherence with cardiac rehabilitation: National survey of UK Services
J. Victory, Bristol (UK)
Long-term adherence factors in exercise based phase IV cardiac rehabilitation
M. Thow, Glasgow (UK)
Uptake of Cardiac Rehab is underestimated by failure to include in-patient rehab and contribution of home based therapy
K. McKeeken, Dumfries (UK)
Cardiac rehabilitation non-adherence after acute coronary syndrome: predictive factors and causes - a randomised prospective study
N. Bettencourt, Porto (PT)

Symposium D3: 'The high risk isles': can we learn from each other?
[Symposium sponsored by the Irish and British Associations of Cardiac Rehabilitation (IACR & BACR)]
Chairs: M. Laher, (IE) and A. McLeod (UK)
Resuscitation training for relative and friends of cardiac patients
S. Ingram, Dublin (IE)
Resuscitation training for relative and friends of cardiac patient
M. Richardson, Edinburgh (UK)
Training for instructors of phase IV cardiac rehabilitation programmes
J. Bell, Ketton (UK)
Training for instructors of phase IV cardiac rehabilitation programmes
N. Moyna, Dublin (IE)
Allocation of scare resources in cardiac rehabilitation
M. Doyle, Limerick (IE)
Allocation of scare resources in cardiac rehabilitation
I. Griebsch, Bristol (UK)

Symposium D4: Sexual dysfunction and cardiovascular disease
[Symposium sponsored by Pfizer]
Chairs: D. Mulcahy, (IE) and P. Fioretti, (IT)
Sex: the heart and erectile difficulties
G. Jackson, London (UK)
Management of erectile dysfunction in elderly cardiovascular patients - new dimensions for an old story
D. Gaita, Timisoara (RO)
Nursing contributions to management of sexual problems in cardiac patients
T. Jaarsma, Groningen (NL)

Symposium D5: Staff challenges in cardiac rehabilitation
Chairs: D. Higginson, (UK) and H. Bethell, (UK)
Do cardiac rehab staff detect, prevent and manage patients problems effectively?
N. Fallon, S Ingram, Dublin (IE)
The perceived problems of cardiac rehabilitation coordinators
HJN Bethell, S Malone, SC Turner, JA Evans, Alton (UK)
Improving the recognition and management of depression in cardiac patients: evaluation of a training workshop for cardiac rehabilitation professionals
P. Reddy, L. Collins, S. Bunker, Melbourne (AU)
Medical surveillance in cardiac rehabilitation
C. King, Ashville (US)
Need for medical supervision during outpatient cardiac rehabilitation
A. Hoffmann, L Joerg, S Piazzalonga, P Rickenbacher, M Pfisterer, Bruderholz (CH)
Traumatologic risk in outpatient cardiac rehabilitation
R. Degenhardt, S Unverdorben, K edel, M Unverdorben, Rotenburg (DE)

Symposium D6: Participation & adherence
Chairs: L. Burke, (US) and D. Hevey, (IE)
Use of classification and regression trees (CART) for predicting non-participation in programmes of cardiac rehabilitation
M. Leibowitz, O Chanukah, D Manor, D David, Kfar Saba (IL)
Factors that influence participation on phase III cardiac rehabilitation programmes
J. Love, J Hussey, J Gormley, V Maher, Dublin (IE)
What factors influence cardiac patients to participate in phase 3 exercise programmes
S. Charles, R Brennan, J caulfield, Dublin (IE)
Systematic review of methods to improve uptake and adherence to cardiac rehabilitation
F.C. Taylor, I. Greibsch, J. Victory, A.D. Beswick, RR West, K Rees, J Brown, S Ebrahim, Birmingham (UK)
A qualitative study of reasons for non-participation and non-adherence at cardiac rehabilitation
S. Greenfield, M Jones, K Jolly, J Raftery, Birmingham (UK)
The influence of cardiac rehabilitation on lifestyle change - one year follow-up
V. Reid, N O’Sullivan, K McDonald, A Clarke, L Daly, Dublin (IE)

Symposium D7: Psychosocial methodologies
Chairs: N. Oldridge, (US) and P. Bennett, (UK)
A new tool for assessing ICD patient concerns: The implanted cardiovascular defibrillator concerns questionnaire (ICD-C)
DJ Frizelle, RJP Lewin, G Kaye, York (UK)
Quality of life after myocardial infarction: specific versus generic questionnaires
E. Vaquerizo, M. Abeyua, T. Martinez Castellanos, F. Duque, F. Ramos, Madrid (ES)
Cultural factors and medication compliance in Chinese immigrants with hypertension
WW Li, ES Froelicher, A Stewart, San Fransisco (US)
Comparing Portuguese MacNew and SF-36 questionnaires after a cardiac rehabilitation
A Rui Leal, C Paiva, S Hofer, J Amado, L Gomes, Porto (PT)
Does a general or a specific questionnaire about quality of life and sexual life in a cardiac rehabilitation programme help?
A Rui Leal, C Paiva, J Amado, L Gomes, Porto (PT)

Symposium D8: Patients beliefs and cardiac rehabilitation
Chairs: B. Hughes, (IE) and J. Weinman, (UK)
Predicting self-efficacy using illness representation components in patients with coronary heart disease: a patient survey
M. Lau-Walker, Surrey (UK)
Understanding how anxiety impacts on patients adjustment post angioplasty/stent
J. Fildes, R. Allan, C. Schniering, B. Khong, S. Chaine, Randwick, (AU)
Health seeing beliefs and behaviours relating to cardiovascular disease in Chinese Australians
J. Daly, P. Davidson, E. Chang, E. Ang, D. Leung, K. Hancock, Penrith (AU)
The effect of misconceptions about angina on physical activity
G. Furze, R.J.P. Lewin, York (UK)
Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour
M. Byrne, C. Leathem , M. Cupples, M. Smith, A.W. Murphy, Dublin (IE)
Patient perceptions of information during cardiac rehabilitation
L. Andersen, C. Sorensen, OS Mortensen, ML Larsen, Fredericia (DK)

Symposium D9: Depression
Chairs: R. Zeigelstein, (US) and D. Hevey, (IE)
Incidence of anxiety, depressive symptoms and their relationship with cardiovascular risk factors in men aged 35-64
GV Pogosova, DV Nebieridze, LD Ozdoeva, VA Vygodin, NS Ivanishina, RG Oganov (RU)
Depression and anxiety in the pre-operative phase for coronary artery bypass graft patients
I. Lie, EH Bunch, G Hamilton, H Arnesen, L Sandvik, Oslo (NO)
Cardiac rehabilitation: the psychological changes that predict health outcome and healthy behaviour
J. Bath, S Michie, D O’Connor, M Giles, J harrison, A Anderson, L Earll, Gloucester (UK)
Cognitive behavioural psychotherapy useful in the management of anxiety and depression in cardiac rehabilitation
P. Pyne-Daly, M Minogue, L Timmons, K Craddock, KM McDonald, Dublin (IE)
Improvement in geriatric depression scale ratings and correlations with descriptive variables among phase II cardiac rehabilitation patients
LA Finucan, ET Fabiano, SA Triplet, NL Goodrich, MS Gburek, Buffalo (US)
Anger in ischemic patients and healthy individuals: implications for intervention in cardiac rehab programmes
C Paiva, R Sousa, A Goncalves, F Martins, A Leal, L Gomes, Porto (PT)

Symposium D10: Cardiovascular risk
Chairs: G. Dalzell, (UK) and G. Fletcher (US)
The evaluation of global cardiovascular risk in three rural communities from Romania
P. Kikeli, Z Preg, M Polinger, M Fejer, D Szentendrey, Targu Mures (RO)
Cardiac risk in WHO Phase III rehabilitation
K. Edel, R Degenhardt, S Unverdoben, M Unverdorben, Rotenburg (DE)
Control of risk factors after coronary artery bypass surgery: results from the Periscop study
P. Sellier, G Chatellier, C Dubois, MC D’Agrosa-Boiteux, H Douard, PC Goepfert, C Monpere, Paris (FR)
A socio-cultural framework of determinants of secondary heart disease prevention
V. Ononeze, AW Murphy, M Byrne, A MacFarlane, C Bradley, Galway (IE)
Mortality reductions in patients receiving exercise based cardiac rehabilitation
RS Taylor, B Unal, JA Critchley, S Capewell, Birmingham (UK)
Smoking status influences cardiac rehabilitation attendance
J Love, J Hussey, J Gormely, V Maher, Dublin (IE)

Symposium D11: Nutrition
Chairs: E. Shelley, (IE)
Dietary Habits Questionnaire (DHQ)
R. Chambers, M. Pullen, P. Vandersee, C. Clarke, L. Smith, S. McKellar Brisbane (AU)
Development and dissemination of nutrition recommendations for cardiac rehabilitation
S. Bunker, N. Tunny, E. van Herwerden, C. Cooper, Melbourne (AU)
Use of weight BMI and waist circumference in a study of the effectiveness of a dietary intervention in a menu-based cardiac rehabilitation programme
D. Syme, T. Johnston, H.K. Whelan, P.D. MacIntyre, Paisley (UK)
CETP Inhibition: a novel approach to the treatment of dyslipidemias
A.G. Digenio,Conneticut (US)
Cardiac rehabilitation programmes are not effective in the management of obesity
A.G. Digenio, P. Sells, Nashville (US)
Hyperhomocysteinemia and response to multivitamin treatment in Asians with coronary heart disease
A.G. Digenio, L.Daly, H. Joughin, L. Klapsidis, Johannesburg (ZA)

Symposium D12: Secondary prevention - through primary care
Chairs: M. Conway, (IE) and J. Wilde, (IE)
The Sphere Study: The development of a complex intervention to improve secondary prevention of coronary heart disease in general practice
M. Byrne, C. Leathem, M. Cupples, S. Smith, A.W. Murphy, Galway (IE)
A pathway to success - completing the cycle of cardiac rehabilitation
M. Hogg, U. Walker, Cleland (UK)
Follow-up of audit patient discharges from the secondary prevention clinic
L. Higginson, E.J. Flint, K. Roy, Wordsley (UK)
A pilot study of a home-based walking programme for non-attenders of cardiac rehabilitation
M. Tully, MEC Cupples, I.S. Young, G. Dalzell, B. Downey, M. Dempster, M. Corrigan, Belfast (UK)
Heart health nurses - facilitating secondary prevention of coronary heart disease in a primary care setting
J. Meiklejohn, P.D. McIntyre, I.N. Findlay, D.C. Davidson, M. White, E. Denny, L.K. Brown, Paisley (UK)
The 4H project: developing a primary care based cardiac rehabilitation service in inner city Nottingham
K. Brown, C. Twells, L. East, J. Radford, M. Quinn, Nottingham (UK)

Symposium E1: Service provision & requirements
Chairs: H. Newton, (IE) and P. Dubach, (CH)
Mapping the provision of cardiac rehabilitation against need in England
H. Bethell, R. Lewin, S. Petersen, S.C. Turner, J.A. Evans, York (UK)
Cardiac rehabilitation service in England: a project proposal for 2003-4
D.A. Brodie, J. Bell, H. Bethel, S.K. Breen, Buckinghamshire (UK)
Shared heart care 1999-2003: have patient outcomes changed?
S.Rosenhain, S. Bunker, S. Johnson, M. Daddo, S. Emery, M. Gaynor, Victoria (AU)
Cardiac rehabilitation information systems: Irish developments in a European context
D. Lavin, D. Hevey, H.M. McGee, D. de la Harpe, M. Kiernan, E. Shelly, Dublin (IE)
A need to treat analysis for cardiac rehabilitation in Austria
W. Benzer, K. Mayr, B. Abbuehl, R. Pokan, B. Greiner Pesau, Feldkirch (AT)

Symposium E2: Home based cardiac rehabilitation
Chairs: P. Kearney (IE) and M. Buchalter (UK)
Cardiac rehabilitation via Telehealth: A University-based training programme for physical therapy students
D.K. Shaw, K.E. Sparks, Texas (US)
The Heart Manual: Effective home-based cardiac rehabilitation
H. Taylor, L.N. Taylor, M.F. Ramsay, Edinburgh (UK)
Evaluation of a telephone-mediated secondary prevention programme following cardiac rehabilitation
O. Mittag, C. China, C. Maurischat, E. Hoberg, E. Jurs, K.D. Kolenda, G. Richardt, H. Raspe, Luebeck (DE)
Transtelephonic electrocardiographic monitoring of an outpatient cardiac rehabilitation programme
E. Kouidi, C. Sipka, A. Farmakiotis, E. Konstantinidou, G. Koukouvou, M. Petraki, A. Deligiannis, Thessaloniki (GR)
Improved access to cardiac rehabilitation: expanded menu-based programme and the patient pathway
M. White, L. Denny, S.M. Catto, H.K. Whelan, P.D. MacIntyre, Paisley (UK)
Home-based cardiac rehabilitation compared with centre-based rehabilitation and usual care: a systematic review and meta-analysis
R.S. Taylor, J. Jolly, G.Y.H. Lip, A. Stevens, Birmingham (UK)

Symposium E3: Delivery systems
Chairs: D. Karoff, (DE) and P. Ades, Vermont (US)
Increasing access through automatic referral to cardiac rehabilitation closest to home
S.L. Grace, E. Evindar, T. Kung, P. Scholey, D.E. Stewart, Toronto (CA)
Cardiac rehabilitation: optimal programme length and patient outcomes
L.F. Hamm, T. Kavanagh, R.B. Campbell, D.J. Mrtens, J. Beyene, J. Kennedy, R.J. Shepard, Washington (US)
A randomised control trial on 6 weeks comprehensive cardiac rehabilitation - the Danrehab study (N=770)
A.D. Zwisler, A. Soja, F. Frederiksen, H. Broennum-Hansen, L. Iversen, B. Sigurd, J. Fischer-Hansen, Copenhagen (DK)
The COACH programme: from clinical trials to clinical practice
MJ Vale, MV Jelinek, JD Best, MB Hoekstra, A Rizzuto, K Thompson, LE Grigg, DL Hare, Melbourne (AUS)
Atlant Cardio: results of a multidisciplinary risk reduction model
I. Hellemans, F. Stam, H. Smid, C. Tittse, R. Pwters, M. Hoogkamer, A. Tump, B. Sari, A. Biesheuvel, R. Sprangers, Amsterdam (NL)
Improving cardiac rehabilitation : the five hearts audit system
J. Perk, P. Johansson, Oskarshamn (SE)

Symposium E4: Cardiac transplantation and rehabilitation post-surgery
Chairs: E. McGovern, (IE) and J. McCarthy, (IE)
Effect of physical training on central chemosensitivity in patients after open-heart surgery
S. Sakurai, H. Adachi, T. Takahashi, M. Azechi, S. Oshima, K. Taniguchi, Maebashi Gunma (JP)
COArctation Long-term Assessment (COALA - Study): Determinants of exercise capacity after surgery for aortic coarctation
A. Hager, W. Koch, H. Stenzel, J. Hess, J. Schober, Munich (DE)
Medical rehabilitation after surgical treatment of ischemic heart disease
K. Lyadov, F. Mukharlyamov, Moscow (RU)
Exercise training improves leg press strength and distance walked in six minutes in cardiac transplant recipients
K. Riess, L. Figgures, A. Dueck, M. Kennedy, L. Jones, W. Tymchak, M. Haykowsky, Alberta (CA)
Does the exercise protocol influence peak VO2 in patients after heart transplantation?
J.P. Schmid, R. Gaillet, M. Noveanu, P. Mahacsi, H. Saner, R. Hullin, Bern (CH)
Exercise prescription for patients after orthotopic heart transplantation
A.G. Digenio, P. Sells, L. White, J. Groves, Nashville (US)

Symposium E5: Heart failure rehabilitation
Chairs: M. Walsh, (IE) and D. Gaita, (RO)
An arbitrary dosage of all parameters of exertion in patients with chronic heart failure provides their optimal level
I.V. Ossipova, Altai (RU)
Long-term exercise training in chronic heart failure
R.M. Nechwatal, M. Horn, D. Flux, U. Lachenmeyer, B. Mochalski, Dahlen (DE)
Safety and longer-term efficacy of cardiac rehabilitation for heart failure
L. Carter, F. Wise, J. Patrick, Victoria (AU)
Some effects of comprehensive out-patient cardiac rehabilitation in patients with chronic heart failure (NYHA I and II)
V. Jonke, I. Heim, M. Svetina, M. Jembrek-Gostovic, M. Hocevar, Zagreb (HR)
Better training outcome for patients with non-ischemic etiology of severe congestive heart failure (CHF)
C. Delagardelle, P. Feiereisen, M. Vaillant, M. Kayser, Luxembourg (LU)
Benificial effect of chronic exercise on the left ventricular diastolic function of healthy male subjects aged 30-45 years
A. Owen, G. O’Donovan, S. Bird, Kent (UK)

Symposium E6: Heart failure & muscle training
Chairs: A. Cohen Solal, (FR) and J. Cantwell, (US)
Relationship of skeletal muscle metabolism with muscle endurance in patients with CHF
J. Jobin, P. Brassard, J. Allaire, J.F. Doyon, N. Martin, C. Simard, M.H. LeBlanc, P. LeBlanc, F. Maltais, Quebec (CA)
Results of a 3 months strength training in severe congestive heart failure (CHF)
P. Feiereisen, M. Kayser, C. Delagardelle, Luxembourg (LU)
Measuring muscle volume and strength to document peripheral training adaptations in congestive heart failure (CHF)
P. Feiereisen, Y. Lasar, C. Delagardelle, Luxembourg (LU)
Inspiratory muscle training using a test of incremental respiratory endurance alleviates dyspenea and improves functional status in patients with heart failure
I. Laoutaris, A. Dritsas, O. Ionescu, A. Manginas, P. Alivizatos, D.V. Cokkinos, M.D. Brown, Athens (GR)
Dynamic exercise in weight lifting by leg press in patients with stable chronic heart failure
U. Schwan, K. Edel, B. Moller, R. Degenhardt, Bad Hermannsborn (DE)
Combined endurance resistance training increases linear isokinetic parameters of skeletal muscles in patients with chronic heart failure
P. Beckers, V. Conraads, N. Possemiers, C. Vrints, Antwerp (BE)

Symposium E7: Interval training
Chairs: N. Moyna, (IE) and S. Adampoulos, (GR)
Impact of different resistance training design on the hemodynamic
M. Lamotte, G. Niset, M. Renard, J.P. Degaute, P. Van de Borne, Brussels (BE)
Influence of interval training on physical capacity and left ventricular function in patients with normal and impaired left ventricle in the course of coronary artery disease
I. Korzeniowska-Kubacka, M. Bilinska, B. Wasilewska, R. Piotrowicz, Warsaw (PL)
Response of isolated low high density lipoprotein cholesterol to high intensity interval training in cardiac patients
M. Bermingham, Y.F. Lui, D. Mahajan, K. Fox, C. Barnes, M.A. Neaverson, Sydney (AU)
The influence of interval training on heart rate frequency in patients with heart failure symptoms during a 2 yearfollow-up programme
I. Korzeniowska-Kubacka, K. Mazurek, E. Rydzewska, R. Piotrowicz, Warsaw (PL)
High intensity interval versus continuous aerobic training in congestive heart failure
P. Koufaki, J. Nolan, T.H. Mercer, Stoke-on-Trent (UK)
The correlation between the clinical state chosen hemodynamic parameters kind of treatment and effects of interval training in patients with heart failure symptoms
K. Mazurek, E. Rydzewska, R. Piotrowicz, Warsaw (PL)

Symposium E8: Exercise and the immune response
Chairs: C. O’Brien, (IE) and J. Myers, (US)
Effects of exercise therepy on lipid metabolism and inflammatory response in ischemic heart disease
M. Nagayama, T. Tobaru, N. Iguchi, K. Misu, R. Asano, E. Magosaki, J. Umemura, T. Sumiyoshi, S. Hosoda, Tokyo (JP)
Beneficial effects of exercise training on interleukin 10 in chronic ischemic heart disease patients
Y. Beniamini, A. Tanchilevitch, E. Goldhammer, Haifa (IL)
Relationship between immune response and exercise effect in cardiac rehabilitation patients
S. Ishihara, S. Makita, S. Sato, R. Nohara, Saitama (JP)
Correction of endothelial dysfunction by exercise training: impact of bradykinin mediated vasodilation
S. Erbs, A. Linke, S. Gielen, J. Bolger, V. Adams, S. Mobius-Winkler, G. Schuler, R. Hambrecht, Leipzig (DE)
Chronic inflammation in stable coronary artery disease: the role of physical exercise
C. Walther, S. Mobius-Winkler, M. Brugel, G.M. Fiedler, S. Gielen, J. Boger, J. Thiery, R. Hambrecht, Leipzig (DE)
Short and long-term exercise training does lead to improved risk factor profile in coronary artery disease and diabetes mellitus type 2 but not to correction of endothelial dysfunction
S. Sixt, T. Peschel, U. Halfwassen, K. Diederich, G. Schuler, J. Niebauer, Leipzig (DE)

Symposium E9: Challenging environments and novel methods
Chairs: D. Murray (IE) and L. Vanhees, (BE)
Tai Chi may be an alternative to traditional excercise
R. E. Taylor-Piliae, E.S. Froelicher, San Fransisco (US)
Select cardiopulmonary responses to lower extremity continuous passive motion exercise
D.K. Shaw, B.L. Sanders, San Marcos (US)
Tilt training as a new rehabilitation method for neurally mediated syncope
T. Reybrouck, H. Heidbuchel, R. Willems, F. Van de Werf, H. Ector, Leuven (BE)
Low cardiovascular impact tennis model (LOCAST): pilot study
H. Ilarraza, A. Del-Villar, J. Chavez, J. Brettnacher, R. Valdez, A. Simon, Mexico City (MX)
Safety and exercise tolerance of acute high-altitude exposure (345M) in patients with coronary heart disease
J.P. Schmid, M. Noveanu, R. Gaillet, G. Hellige, A. Wahl, H. Saner, Bern (CH)
Aquatic cardiac rehabilitation programme at hospital S. Sebastiao - Feira – Portugal
C. Branco, M.J. Ferreira, Feira (PT)

Symposium E10: Management Strategies: new developments
Chairs: P. Nichols (IE) and H. Goelke, (DE)
Comparison of teaching methods for achieving cognitive learning objectives in outpatient cardiac rehabilitation patients
D. Waechter, J. Hughes, J. Rosneck, R. Josephson, Akron (US)
Changing models not rooms
L. Earl, J. Bath, A. Anderson, G. Bohin, M. Gallagher, Gloucester (UK)
Goal setting in cardiac rehabilitation
H. Hamalainen, M. Röberg, T. Klaukka, Turku (FI)
Efficacy of two strategies using cardiac rehabilitation nurses to promote long-term adherence to lifestyle changes and to medical treatment in patients with coronary artery disease
M. Vona, S. Rizzo, M. De Marchi, M. Rabaeus, Aosta (IT)
Motivational interviewing to improve exercise uptake in coronary heart disease patients
L. Speck, C. Lane, S. Rollnick, A. Cook, Wales (UK)
Managing distress in cardiac rehabilitation: what do staff need?
N. Robertson, K. Ceaser, S.Singh, Leicester. (UK)

Symposium E11: Gender and Cardiac Rehabilitation 1
Chairs: C. Wilson, (UK) and N. Wenger, (US)
Effects of gender on symptoms and health status in unpartnered cardiac surgical elders
D. L. Carroll , G.A. Hamilton, S.H. Rankin, Boston (US)
GROW: A cardiac rehabilitation programme for older women
J. Daly, P. Davidson, J. Cockburn, E. Chang, K Hancock, Penrith (AU)
Rehabilitation of women with acute myocardial infarction
A. Kuimov , N. Loshkina, V. Stukhljaev, N Kasina, N Kinash, Novosibirsk (RU)
Women in Cardiac Rehabilitation: Baseline characteristics and outcomes
B. K. Sanderson, J. Breland, C. Schumann, V. Bittner, Birmingham (US)
The implementation of secondary prevention in female patients with established coronary artery disease
L. Abboud, J. Hir, I. Eisen, W. Markiewicz, Haifa, (IL)
Women’s health principles applied to cardiac rehabilitation - a Canadian experience
M. Landry, D. Childerhose, F. Delos-Reyes, Ontario (CA)

Symposium E12: Gender and Cardiac Rehabilitation ll
Chairs: H. Dunne, (UK) and C. Kelliher, (IE)
Assessment of physical capacity and cardiac events in rehabilitated patients after thrombolytic therapy or primary PTCA in acute phase of infarction
I. Korzeniowska-Kubacka, K. Mazurek, M. Bilinska, E. Rydzewska, Warsaw (PL)
Gender differences in depressive mood after a cardiac event: evaluation of rehabilitation programmes
S. Norrman, B. Stegmayr, M. Eriksson , B. Hedbäck, G. Burell, C. Brulin, Umeå, (SE)
Gender differences in influence of social support on timely arrival at hospital during myocardial infarction
H. Aikman, H. McBurney, Victoria (AU)
Influence of gender on anxiety and depression scores in coronary patients
S. Dragan, S. Mancas, D. Nutiu, S. Ursoniu, C. Vernic, S. Popescu, M. Rada, S.I. Dragulescu, Timisoara, (RO)
Characteristics, gender differences and reference equations for the six minute walk test in heart failure
L. Cahalin, S.M. Collins, GW Dec, MJ Semigran, Boston (US)

POSTER ABSTRACTS
There will be approximately 200 Poster abstract presentations during the three days for the congress.

INSTRUCTIONS FOR POSTER PRESENTATIONS:
How to prevent poster fatigue
1) Your poster will be no more than 90cms wide and 120cms high. do not exceed these size limits. velcro will be provided for mounting

2) At the top of the poster there should be a banner indicating the title, authors & institutions. the lettering for this section should be not less than 2.5cms (1 inch) high.

3) Text in the body of the poster should be at least 1cm (3/8 inch) high, preferably in bold font.

4) Keep everything as simple as possible. Block lettering may be used to add clarity & emphasis. Captions should be brief & labels few & clear.

5) It is helpful if the sequence to be followed in studying your material is indicated by numbers, letters or arrows. Remember that your text and illustrations will be viewed from distances of one metre or more. references should be given

6) Authors must be available at their poster during the designated poster viewing sessions and should be willing to discuss points arising with attendees.

7) A4 or A3 folded copies of the poster are sometimes useful as hand-outs for interested viewers.

8) You may wish to put your e-mail address onto the poster as an easy point of contact for interested viewers

REFERENCE
Woolsey JD. combating poster fatigue: how to use visual grammar and analysis to effect better visual communication

Trends in Neuroscience's 12(9); 325-32,1989.